Diabetes PubMed

These preliminary findings suggest associations of short sleep duration and snoring with glucose intolerance and gestational diabetes mellitus (GDM).

The frequency of postpartum follow-up for women diagnosed with gestational diabetes mellitus is exceedingly low. More effective strategies are needed to increase the postpartum and longitudinal follow-up for all women with gestational diabetes mellitus.

Evidence derived from recent randomized controlled trials indicates that gestational diabetes mellitus (GDM) treatment reduces newborn obesity and therefore may contribute to reducing the global prevalence of obesity and metabolic syndrome.

Despite the better detection of gestational diabetes mellitus (GDM) and recognition of its adverse consequences for mother and baby in many countries, there is still no consensus regarding GDM pathophysiology; as a result, diagnosis and treatment of GDM remain controversial.

However, we are not confident that this (exercise) intervention would be sufficient to prevent gestational diabetes (GDM).

Women with gestational diabetes mellitus show a significant increase in fat mass without significant changes in the fat free mass and total body water.

Therefore, neither metformin nor glibenclamide can yet have an established place as monotherapies in gestational diabetes; they can be used only in exceptionally cases.

Fasting plasma glucose is a better investigation for the screening of gestational diabetes than plasma glucose post 50-g glucose challenge.

Accu-Chek Advantage is suitable for screening gestational diabetes using the optimal threshold capillary glucose level of 140 mg/dl.

Women with preeclampsia have greater risk of developing diabetes, even in the absence of gestational diabetes.